Chronic Myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and management
出版年份 2019 全文链接
标题
Chronic Myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and management
作者
关键词
-
出版物
AMERICAN JOURNAL OF HEMATOLOGY
Volume 95, Issue 1, Pages 97-115
出版商
Wiley
发表日期
2019-11-18
DOI
10.1002/ajh.25684
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Clinical correlates, prognostic impact and survival outcomes in chronic myelomonocytic leukemia patients with the JAK2V617F mutation
- (2019) Mrinal M. Patnaik et al. HAEMATOLOGICA
- Biology and prognostic impact of clonal plasmacytoid dendritic cells in chronic myelomonocytic leukemia
- (2019) Nolwenn Lucas et al. LEUKEMIA
- Suboptimal response rates to hypomethylating agent therapy in chronic myelomonocytic leukemia; a single institutional study of 121 patients
- (2019) Tucker Coston et al. AMERICAN JOURNAL OF HEMATOLOGY
- Proposed diagnostic criteria for classical CMML, CMML variants and pre-CMML conditions
- (2019) Peter Valent et al. HAEMATOLOGICA
- An oral fixed-dose combination of decitabine and cedazuridine in myelodysplastic syndromes: a multicentre, open-label, dose-escalation, phase 1 study
- (2019) Michael R Savona et al. Lancet Haematology
- Guadecitabine (SGI-110) in patients with intermediate or high-risk myelodysplastic syndromes: phase 2 results from a multicentre, open-label, randomised, phase 1/2 trial
- (2019) Guillermo Garcia-Manero et al. Lancet Haematology
- Practical limitations of monocyte subset repartitioning by multiparametric flow cytometry in chronic myelomonocytic leukemia
- (2019) Prateek A. Pophali et al. Blood Cancer Journal
- Clonal hematopoiesis in human aging and disease
- (2019) Siddhartha Jaiswal et al. SCIENCE
- Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management
- (2018) Mrinal M. Patnaik et al. AMERICAN JOURNAL OF HEMATOLOGY
- Cooperative Epigenetic Remodeling by TET2 Loss and NRAS Mutation Drives Myeloid Transformation and MEK Inhibitor Sensitivity
- (2018) Hiroyoshi Kunimoto et al. CANCER CELL
- Blast phase chronic myelomonocytic leukemia: Mayo-MDACC collaborative study of 171 cases
- (2018) Mrinal M. Patnaik et al. LEUKEMIA
- FGFR1 rearranged hematological neoplasms – molecularly defined and clinically heterogeneous
- (2018) Mrinal M. Patnaik et al. LEUKEMIA & LYMPHOMA
- Infrequent occurrence of TET1, TET3, and ASXL2 mutations in myelodysplastic/myeloproliferative neoplasms
- (2018) Terra L. Lasho et al. Blood Cancer Journal
- EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimental
- (2018) Mrinal M. Patnaik et al. Blood Cancer Journal
- Prognostic Role of Gene Mutations in Chronic Myelomonocytic Leukemia Patients Treated With Hypomethylating Agents
- (2018) Matthieu Duchmann et al. EBioMedicine
- Biallelic inactivation of the retinoblastoma gene results in transformation of chronic myelomonocytic leukemia to a blastic plasmacytoid dendritic cell neoplasm: shared clonal origins of two aggressive neoplasms
- (2018) Mrinal M. Patnaik et al. Blood Cancer Journal
- Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117
- (2017) Mikkael A. Sekeres et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia
- (2017) V Santini et al. LEUKEMIA
- Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
- (2017) Siddhartha Jaiswal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Flow cytometry based monocyte subset analysis accurately distinguishes chronic myelomonocytic leukemia from myeloproliferative neoplasms with associated monocytosis
- (2017) M M Patnaik et al. Blood Cancer Journal
- Next generation sequencing of myeloid neoplasms with eosinophilia harboring theFIP1L1-PDGFRAmutation
- (2016) Animesh Pardanani et al. AMERICAN JOURNAL OF HEMATOLOGY
- Targeted next generation sequencing of PDGFRB rearranged myeloid neoplasms with monocytosis
- (2016) Mrinal M. Patnaik et al. AMERICAN JOURNAL OF HEMATOLOGY
- DNMT3A mutations are associated with inferior overall and leukemia-free survival in chronic myelomonocytic leukemia
- (2016) Mrinal M. Patnaik et al. AMERICAN JOURNAL OF HEMATOLOGY
- Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival for Patients with Chronic Myelomonocytic Leukemia
- (2016) Piyanuch Kongtim et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia
- (2016) C. Elena et al. BLOOD
- When clinical heterogeneity exceeds genetic heterogeneity: thinking outside the genomic box in chronic myelomonocytic leukemia
- (2016) M. Ball et al. BLOOD
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
- (2016) D. A. Arber et al. BLOOD
- The Role of New Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
- (2016) Priyanka A. Pophali et al. CANCER JOURNAL
- A Multi-Institution Phase I Trial of Ruxolitinib in Patients with Chronic Myelomonocytic Leukemia (CMML)
- (2016) E. Padron et al. CLINICAL CANCER RESEARCH
- Spectrum of autoimmune diseases and systemic inflammatory syndromes in patients with chronic myelomonocytic leukemia
- (2016) Mohammad Faizan Zahid et al. LEUKEMIA & LYMPHOMA
- Chronic Myelomonocytic Leukemia: Focus on Clinical Practice
- (2016) Mrinal M. Patnaik et al. MAYO CLINIC PROCEEDINGS
- Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents
- (2016) Jane Merlevede et al. Nature Communications
- Number and type of TET2 mutations in chronic myelomonocytic leukemia and their clinical relevance
- (2016) M M Patnaik et al. Blood Cancer Journal
- Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia
- (2016) M M Patnaik et al. Blood Cancer Journal
- Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemia
- (2016) M M Patnaik et al. Blood Cancer Journal
- Blast transformation in chronic myelomonocytic leukemia: Risk factors, genetic features, survival, and treatment outcome
- (2015) Mrinal M. Patnaik et al. AMERICAN JOURNAL OF HEMATOLOGY
- Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia
- (2015) D. Selimoglu-Buet et al. BLOOD
- An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults
- (2015) M. R. Savona et al. BLOOD
- Patients With Therapy-Related CMML Have Shorter Median Overall Survival Than Those With De Novo CMML: Mayo Clinic Long-Term Follow-Up Experience
- (2015) Salih Subari et al. Clinical Lymphoma Myeloma & Leukemia
- Age-related mutations and chronic myelomonocytic leukemia
- (2015) C C Mason et al. LEUKEMIA
- Cancer-associated ASXL1 mutations may act as gain-of-function mutations of the ASXL1–BAP1 complex
- (2015) Anand Balasubramani et al. Nature Communications
- ASXL1 mutated chronic myelomonocytic leukemia in a patient with familial thrombocytopenia secondary to germline mutation in ANKRD26
- (2015) J Perez Botero et al. Blood Cancer Journal
- Erratum: Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome
- (2015) M M Patnaik et al. Blood Cancer Journal
- An international data set for CMML validates prognostic scoring systems and demonstrates a need for novel prognostication strategies
- (2015) E Padron et al. Blood Cancer Journal
- A Close Association of Autoimmune-Mediated Processes and Autoimmune Disorders with Chronic Myelomonocytic Leukemia: Observation from a Single Institution
- (2014) Deniz Peker et al. ACTA HAEMATOLOGICA
- Cytogenetic risk stratification of 417 patients with chronic myelomonocytic leukemia from a single institution
- (2014) Guilin Tang et al. AMERICAN JOURNAL OF HEMATOLOGY
- Molecular and prognostic correlates of cytogenetic abnormalities in chronic myelomonocytic leukemia: a Mayo Clinic-French Consortium Study
- (2014) Emnet A. Wassie et al. AMERICAN JOURNAL OF HEMATOLOGY
- TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients
- (2014) R. Bejar et al. BLOOD
- Chronic myelomonocytic leukaemia: a concise clinical and pathophysiological review
- (2014) Mrinal M. Patnaik et al. BRITISH JOURNAL OF HAEMATOLOGY
- A multi-centre phase 2 study of azacitidine in chronic myelomonocytic leukaemia
- (2014) M W Drummond et al. LEUKEMIA
- ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients
- (2014) M M Patnaik et al. LEUKEMIA
- Azacitidine in CMML: Matched-pair analyses of daily-life patients reveal modest effects on clinical course and survival
- (2014) Lisa Pleyer et al. LEUKEMIA RESEARCH
- What is a promonocyte?
- (2013) Barbara J. Bain AMERICAN JOURNAL OF HEMATOLOGY
- Mutations in epigenetic modifiers in the pathogenesis and therapy of acute myeloid leukemia
- (2013) O. Abdel-Wahab et al. BLOOD
- GM-CSF-dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemia
- (2013) E. Padron et al. BLOOD
- Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia
- (2013) E. Such et al. BLOOD
- Clinical characteristics and outcomes of therapy-related chronic myelomonocytic leukemia
- (2013) K. Takahashi et al. BLOOD
- Clonal architecture of chronic myelomonocytic leukemias
- (2013) R. Itzykson et al. BLOOD
- Allogeneic stem cell transplantation for chronic myelomonocytic leukemia: a report from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire
- (2013) Sophie Park et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Role of Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem-Cell Transplantation in Older Patients With De Novo Myelodysplastic Syndromes: An International Collaborative Decision Analysis
- (2013) John Koreth et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia
- (2013) Raphaël Itzykson et al. JOURNAL OF CLINICAL ONCOLOGY
- An evolutionary perspective on chronic myelomonocytic leukemia
- (2013) R Itzykson et al. LEUKEMIA
- SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias
- (2013) F Damm et al. LEUKEMIA
- SETBP1 mutations in 415 patients with primary myelofibrosis or chronic myelomonocytic leukemia: independent prognostic impact in CMML
- (2013) R R Laborde et al. LEUKEMIA
- Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes
- (2013) M M Patnaik et al. LEUKEMIA
- Predictive factors of response and survival among chronic myelomonocytic leukemia patients treated with azacitidine
- (2013) Lionel Adès et al. LEUKEMIA RESEARCH
- FLT3mutations in myelodysplastic syndrome and chronic myelomonocytic leukemia
- (2012) Naval Daver et al. AMERICAN JOURNAL OF HEMATOLOGY
- Spliceosome mutations involvingSRSF2,SF3B1, andU2AF35in chronic myelomonocytic leukemia: Prevalence, clinical correlates, and prognostic relevance
- (2012) Mrinal M. Patnaik et al. AMERICAN JOURNAL OF HEMATOLOGY
- Prognostic irrelevance of ring sideroblast percentage in World Health Organization-defined myelodysplastic syndromes without excess blasts
- (2012) M. M. Patnaik et al. BLOOD
- SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)
- (2012) M. Meggendorfer et al. BLOOD
- ASXL1 Mutations Promote Myeloid Transformation through Loss of PRC2-Mediated Gene Repression
- (2012) Omar Abdel-Wahab et al. CANCER CELL
- Effects ofTET2mutations on DNA methylation in chronic myelomonocytic leukemia
- (2012) Jumpei Yamazaki et al. Epigenetics
- Impact of Azacitidine Before Allogeneic Stem-Cell Transplantation for Myelodysplastic Syndromes: A Study by the Société Française de Greffe de Moelle et de Thérapie-Cellulaire and the Groupe-Francophone des Myélodysplasies
- (2012) Gandhi Damaj et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment of chronic myelomonocytic leukemia with azacitidine
- (2012) Eric Wong et al. LEUKEMIA & LYMPHOMA
- High rate of remissions in chronic myelomonocytic leukemia treated with 5-azacytidine: results of an Italian retrospective study
- (2012) Luana Fianchi et al. LEUKEMIA & LYMPHOMA
- Treatment of chronic myelomonocytic leukemia with 5-Azacitidine: A case series and literature review
- (2012) Michael Thorpe et al. LEUKEMIA RESEARCH
- Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A
- (2011) A. M. Jankowska et al. BLOOD
- SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value
- (2011) M. M. Patnaik et al. BLOOD
- Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trial
- (2011) T. Braun et al. BLOOD
- Phase I Study of Oral Azacitidine in Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, and Acute Myeloid Leukemia
- (2011) Guillermo Garcia-Manero et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevance
- (2011) V Grossmann et al. LEUKEMIA
- Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms
- (2011) O Abdel-Wahab et al. LEUKEMIA
- Cutaneous manifestations in CMML: Indication of disease acceleration or transformation to AML and review of the literature
- (2011) Rahel A. Mathew et al. LEUKEMIA RESEARCH
- Frequent pathway mutations of splicing machinery in myelodysplasia
- (2011) Kenichi Yoshida et al. NATURE
- Allogeneic Hematopoietic Cell Transplantation for Chronic Myelomonocytic Leukemia: Relapse-Free Survival Is Determined by Karyotype and Comorbidities
- (2010) Hesham Eissa et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic value
- (2010) A. E. Smith et al. BLOOD
- Nomenclature of monocytes and dendritic cells in blood
- (2010) L. Ziegler-Heitbrock et al. BLOOD
- Allogeneic haematopoietic SCT for chronic myelomonocytic leukaemia: a single-centre experience
- (2010) P Krishnamurthy et al. BONE MARROW TRANSPLANTATION
- ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia
- (2010) Véronique Gelsi-Boyer et al. BRITISH JOURNAL OF HAEMATOLOGY
- Activity of azacitidine in chronic myelomonocytic leukemia
- (2010) Rubens Costa et al. CANCER
- RAS Mutations Contribute to Evolution of Chronic Myelomonocytic Leukemia to the Proliferative Variant
- (2010) C. Ricci et al. CLINICAL CANCER RESEARCH
- Transcription factor mutations in myelodysplastic/myeloproliferative neoplasms
- (2010) T. Ernst et al. HAEMATOLOGICA
- Cytogenetic risk stratification in chronic myelomonocytic leukemia
- (2010) E. Such et al. HAEMATOLOGICA
- Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 72.8% of Chronic Myelomonocytic Leukemia by Detecting Frequent Alterations in TET2, CBL, RAS, and RUNX1
- (2010) Alexander Kohlmann et al. JOURNAL OF CLINICAL ONCOLOGY
- Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies
- (2009) O. Abdel-Wahab et al. BLOOD
- PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model
- (2009) L. Zhang et al. BLOOD
- Mutations of E3 Ubiquitin Ligase Cbl Family Members Constitute a Novel Common Pathogenic Lesion in Myeloid Malignancies
- (2009) Hideki Makishima et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
- (2009) Pierre Fenaux et al. LANCET ONCOLOGY
- Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML
- (2009) A Tefferi et al. LEUKEMIA
- RUNX1 mutations are frequent in chronic myelomonocytic leukemia and mutations at the C-terminal region might predict acute myeloid leukemia transformation
- (2009) M-C Kuo et al. LEUKEMIA
- Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs
- (2008) D. E. Rollison et al. BLOOD
- Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1genes
- (2008) Véronique Gelsi-Boyer et al. BMC CANCER
- Outcome of allo-SCT for chronic myelomonocytic leukemia
- (2008) S Ocheni et al. BONE MARROW TRANSPLANTATION
- Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System
- (2008) Hagop Kantarjian et al. CANCER
- On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia
- (2008) E J Feldman et al. LEUKEMIA
- Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML)
- (2007) P.W. Wijermans et al. LEUKEMIA RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now